Cargando…
Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia
Macrophage Activation Syndrome (MAS) is a potentially fatal inflammatory condition that can rapidly lead to multi-organ failure if inadequately treated. Also, known as secondary Hemophagocytic Lymphohistiocytosis (sHLH), MAS is commonly seen as a complication of systemic inflammatory disorders, like...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671734/ https://www.ncbi.nlm.nih.gov/pubmed/33235686 http://dx.doi.org/10.1080/20009666.2020.1787811 |
_version_ | 1783610984258076672 |
---|---|
author | Awasthi, Shankar Upreti, Sunita |
author_facet | Awasthi, Shankar Upreti, Sunita |
author_sort | Awasthi, Shankar |
collection | PubMed |
description | Macrophage Activation Syndrome (MAS) is a potentially fatal inflammatory condition that can rapidly lead to multi-organ failure if inadequately treated. Also, known as secondary Hemophagocytic Lymphohistiocytosis (sHLH), MAS is commonly seen as a complication of systemic inflammatory disorders, like systemic juvenile idiopathic arthritis (sJIA) and systemic lupus erythematosus (SLE). However, MAS can also present as a complication of malignancies and infections, particularly viral infections like Epstein-Barr virus (EBV), cytomegalovirus (CMV) and HIV. Here we describe a patient with an underlying history of SLE and Sjogren’s disease who was found have both EBV and CMV infections, presented to our facility with fever, lymphadenopathy, pneumonia and pancytopenia. Patient was treated in line with sepsis in the intensive care unit but rapidly developed multigrain failure despite early aggressive treatment. As will be discussed below, patient had characteristic signs and symptoms of MAS with biochemical parameters pointing towards the same. |
format | Online Article Text |
id | pubmed-7671734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-76717342020-11-23 Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia Awasthi, Shankar Upreti, Sunita J Community Hosp Intern Med Perspect Case Report Macrophage Activation Syndrome (MAS) is a potentially fatal inflammatory condition that can rapidly lead to multi-organ failure if inadequately treated. Also, known as secondary Hemophagocytic Lymphohistiocytosis (sHLH), MAS is commonly seen as a complication of systemic inflammatory disorders, like systemic juvenile idiopathic arthritis (sJIA) and systemic lupus erythematosus (SLE). However, MAS can also present as a complication of malignancies and infections, particularly viral infections like Epstein-Barr virus (EBV), cytomegalovirus (CMV) and HIV. Here we describe a patient with an underlying history of SLE and Sjogren’s disease who was found have both EBV and CMV infections, presented to our facility with fever, lymphadenopathy, pneumonia and pancytopenia. Patient was treated in line with sepsis in the intensive care unit but rapidly developed multigrain failure despite early aggressive treatment. As will be discussed below, patient had characteristic signs and symptoms of MAS with biochemical parameters pointing towards the same. Taylor & Francis 2020-09-03 /pmc/articles/PMC7671734/ /pubmed/33235686 http://dx.doi.org/10.1080/20009666.2020.1787811 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Awasthi, Shankar Upreti, Sunita Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia |
title | Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia |
title_full | Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia |
title_fullStr | Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia |
title_full_unstemmed | Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia |
title_short | Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia |
title_sort | macrophage activation syndrome in a patient with systemic lupus erythematosus (sle) and dual viremia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671734/ https://www.ncbi.nlm.nih.gov/pubmed/33235686 http://dx.doi.org/10.1080/20009666.2020.1787811 |
work_keys_str_mv | AT awasthishankar macrophageactivationsyndromeinapatientwithsystemiclupuserythematosussleanddualviremia AT upretisunita macrophageactivationsyndromeinapatientwithsystemiclupuserythematosussleanddualviremia |